The Venture Codex Logo

The Venture Codex

Lilly Asia Ventures

Room 2909-17, Infinitus Tower, 168 Hubin Road, Huangpu, Shanghai, 200021, China

Overview

Venture capital investments in life science companies in Asia.

Founded

2008

Deals ยท 12mo

14

Links

WebsiteLinkedIn

Stage focus

Series A
Series B
Series C

Geographic focus

China
United States

Sector focus

Biotechnology
Pharmaceutical
Venture Capital

Investment portfolio

125rounds
NAMEDATESIZE
NeuShen Therapeutics
Sep 2026Participated
$80 MSeries B
Convergen
Aug 2026Participated
$15 MSeed
Khartis Therapeutics
Aug 2026Participated
$50 MSeries B
Accro Bioscience
May 2026Participated
$50 MSeries C
Pam Medical
Apr 2026Participated
$100 MSeries D
Pulnovo Medical
Apr 2026Participated
$100 MOther Equity
Syneron Bio
Apr 2026Participated
$150 MSeries B
StairMed
Apr 2026Participated
$73 MOther Equity
Pinnacle Medicines
Mar 2026Led
$89 MSeries B
Excalipoint Therapeutics
Mar 2026Participated
$28 MSeed
QuantX Biosciences
Feb 2026Led
$85 MSeries B
Precede Biosciences
Jan 2026Participated
$84 MSeries B
NeuShen Therapeutics
Sep 2026Participated
$80 MSeries B
Convergen
Aug 2026Participated
$15 MSeed
Khartis Therapeutics
Aug 2026Participated
$50 MSeries B
Accro Bioscience
May 2026Participated
$50 MSeries C
Pam Medical
Apr 2026Participated
$100 MSeries D
Pulnovo Medical
Apr 2026Participated
$100 MOther Equity
Syneron Bio
Apr 2026Participated
$150 MSeries B
StairMed
Apr 2026Participated
$73 MOther Equity
Pinnacle Medicines
Mar 2026Led
$89 MSeries B
Excalipoint Therapeutics
Mar 2026Participated
$28 MSeed
QuantX Biosciences
Feb 2026Led
$85 MSeries B
Precede Biosciences
Jan 2026Participated
$84 MSeries B
125
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Lilly Asia Ventures: 125 funding rounds are recorded in the selected participation categories.All available history.
Lilly Asia Ventures: 125 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed12
Series A622
Series B1139
Series C+426
Other Equity58
Debt01

Monthly Deal Activity

Lilly Asia Ventures: 125 deals are recorded across 150 months.All available history.
Lilly Asia Ventures: 125 deals are recorded across 150 months. All available history
MonthDeals
May '141
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '140
Jan '151
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '151
Oct '151
Nov '150
Dec '150
Jan '162
Feb '161
Mar '160
Apr '160
May '160
Jun '160
Jul '161
Aug '161
Sep '162
Oct '161
Nov '160
Dec '160
Jan '170
Feb '171
Mar '170
Apr '170
May '172
Jun '170
Jul '171
Aug '171
Sep '171
Oct '170
Nov '170
Dec '170
Jan '181
Feb '180
Mar '182
Apr '182
May '182
Jun '182
Jul '181
Aug '182
Sep '181
Oct '182
Nov '182
Dec '180
Jan '190
Feb '195
Mar '191
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '193
Oct '191
Nov '191
Dec '190
Jan '201
Feb '200
Mar '200
Apr '202
May '200
Jun '200
Jul '200
Aug '202
Sep '204
Oct '204
Nov '202
Dec '204
Jan '211
Feb '211
Mar '212
Apr '212
May '214
Jun '213
Jul '212
Aug '215
Sep '211
Oct '212
Nov '211
Dec '210
Jan '221
Feb '220
Mar '220
Apr '221
May '220
Jun '220
Jul '220
Aug '221
Sep '221
Oct '220
Nov '220
Dec '220
Jan '231
Feb '231
Mar '231
Apr '230
May '230
Jun '230
Jul '230
Aug '231
Sep '231
Oct '231
Nov '230
Dec '230
Jan '242
Feb '242
Mar '241
Apr '240
May '240
Jun '240
Jul '240
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '251
Apr '250
May '252
Jun '250
Jul '250
Aug '250
Sep '252
Oct '250
Nov '250
Dec '252
Jan '261
Feb '261
Mar '262
Apr '264
May '261
Jun '260
Jul '260
Aug '262
Sep '261
Oct '260

Sector Breakdown

Lilly Asia Ventures: Health & Life Sciences is the largest displayed sector by deal count (123 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Lilly Asia Ventures: Health & Life Sciences is the largest displayed sector by deal count (123 deals). All available history
SectorDeals
Health & Life Sciences123
Manufacturing10
Space & Frontier Tech5
Hardware & Robotics3
AI & Machine Learning3
Fintech1
Cybersecurity & Privacy1
Professional Services1
Consumer & Lifestyle1

Deal Size Distribution

Lilly Asia Ventures: 125 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Lilly Asia Ventures: 125 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M18
$25M-$50M22
$50M-$100M47
$100M-$250M33
$250M-$500M5
$500M-$1B0
$1B+0

Deals By Geography

Lilly Asia Ventures: United States has the largest recorded deal count among the displayed regions (62 deals).All available history.

Top 7 of 7 regions; European countries are grouped as Europe.

Lilly Asia Ventures: United States has the largest recorded deal count among the displayed regions (62 deals). All available history
RegionDeals
United States62
China57
Europe2
Hong Kong1
Israel1
P.R.China1
South Africa1
Lilly Asia Ventures: 20 co-investors are shown, with OrbiMed sharing 34 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Lilly Asia Ventures: 20 co-investors are shown, with OrbiMed sharing 34 recorded deals. All available history
Co-investorShared deals
OrbiMed34
Vivo Capital16
Hongshan Capital Group (Sequoia Capital China)14
Qiming Venture Partners14
Cormorant Asset Management12
Matrix Partners China12
ARCH Venture Partners11
Alexandria Venture Investments9
IDG Capital8
RA Capital Management8
Foresite Capital7
HBM Healthcare Investments7
Octagon Capital7
SR One7
Ally Bridge Group6
Casdin Capital6
Legend Capital6
Logos Capital6
LYFE Capital6
Quan Capital6

Investment Strategy

Lilly Asia Ventures: Led accounts for 22% and participating for 78% of round participation.All available history.
Lilly Asia Ventures: Led accounts for 22% and participating for 78% of round participation. All available history
CategoryDeals (count)Share (%)
Led2722%
Participating9878%
Lilly Asia Ventures: Single-lead accounts for 56% and co-led for 44% of lead dynamics.All available history.
Lilly Asia Ventures: Single-lead accounts for 56% and co-led for 44% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1556%
Co-led1244%

Team

Jiaxin Li

partner

Judith Li

Partner

Yi Shi

Managing Director & Founder